-
Study aim
-
Evaluation of the outcomes of the Enhanced View-Totally Extra-peritoneal (eTEP) technique for repair of inguinal hernia after radical prostatectomy
-
Design
-
A controlled clinical trial with paralleled groups of intervention (eTEP) and control (TAPP), without blinding, non-randomized, phase 3, with a sample size of 15 in each group.
-
Settings and conduct
-
This Phase 3 clinical trial evaluates patients by a general surgeon (laparoscopic fellowship) who reviews their history and examines them. If an inguinal hernia is diagnosed after radical prostatectomy, its type and suitability for extended total extraperitoneal surgery are assessed. Eligible patients are enrolled. An equal number in the other group undergo transabdominal preperitoneal surgery. Patients are selected and categorized through census sampling, not randomly. The sample size is 15 per group.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Inguinal hernia diagnosis, Informed written consent, eligibility for laparoscopic surgery, absence of contra-indication for laparoscopic surgery,
Exclusion criteria: hematologic and severe comorbidities, psychological and cognitive disorders, and generalized infectious disease
-
Intervention groups
-
The intervention groups will be operated with the eTEP technique, and the control group will be operated with the Transabdominal Preperitoneal (TAPP) technique.
-
Main outcome variables
-
Patients will undergo an ultrasound examination the day after surgery to identify any hematomas, seromas, or potential mesh displacements. Pain levels will be assessed using the Visual Analog Scale (VAS). Follow-up will be conducted via a questionnaire, either in-person if necessary or otherwise by phone. The following outcomes will be evaluated: Pain severity, surgery complications, vascular injury, bladder injury, intestine injury, and duration to regain pre-surgical daily abilities.